{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:47:29Z","timestamp":1789228049640,"version":"build-2803163510"},"publisher-location":"Cham","reference-count":101,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030829834","type":"print"},{"value":"9783030829841","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/164_2021_446","type":"book-chapter","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T23:02:19Z","timestamp":1615330939000},"page":"253-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Brain Plasma Membrane Monoamine Transporter in Health and Disease"],"prefix":"10.1007","author":[{"given":"Let\u00edcia S.","family":"Vieira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"446_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2040-2392-5-43","volume":"5","author":"D Adamsen","year":"2014","unstructured":"Adamsen D, Ramaekers V, Ho HTB et al (2014) Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene. Mol Autism 5:1\u201311. https:\/\/doi.org\/10.1186\/2040-2392-5-43","journal-title":"Mol Autism"},{"key":"446_CR2","doi-asserted-by":"publisher","unstructured":"Agnati LF, Guidolin D, Guescini M et al (2010) Understanding wiring and volume transmission. Brain Res Rev 64:137\u2013159. https:\/\/doi.org\/10.1016\/j.brainresrev.2010.03.003","DOI":"10.1016\/j.brainresrev.2010.03.003"},{"key":"446_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2147\/PPA.S29716","volume":"6","author":"KS Al-Harbi","year":"2012","unstructured":"Al-Harbi KS (2012) Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence 6:369\u2013388. https:\/\/doi.org\/10.2147\/PPA.S29716","journal-title":"Patient Prefer Adherence"},{"key":"446_CR4","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.neuropharm.2006.01.005","volume":"50","author":"A Amphoux","year":"2006","unstructured":"Amphoux A, Vialou V, Drescher E et al (2006) Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 50:941\u2013952. https:\/\/doi.org\/10.1016\/j.neuropharm.2006.01.005","journal-title":"Neuropharmacology"},{"key":"446_CR5","doi-asserted-by":"publisher","first-page":"18976","DOI":"10.1073\/pnas.0800466105","volume":"105","author":"NL Baganz","year":"2008","unstructured":"Baganz NL, Hortona RE, Calderon AS et al (2008) Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci U S A 105:18976\u201318981. https:\/\/doi.org\/10.1073\/pnas.0800466105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"446_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00424-003-1103-2","volume":"447","author":"SA Baldwin","year":"2004","unstructured":"Baldwin SA, Beal PR, Yao SYM et al (2004) The equilibrative nucleoside transporter family, SLC29. Pflugers Arch Eur J Physiol 447:735\u2013743. https:\/\/doi.org\/10.1007\/s00424-003-1103-2","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"446_CR7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1161\/01.RES.0000238359.18495.42","volume":"99","author":"K Barnes","year":"2006","unstructured":"Barnes K, Dobrzynski H, Foppolo S et al (2006) Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ Res 99:510\u2013519. https:\/\/doi.org\/10.1161\/01.RES.0000238359.18495.42","journal-title":"Circ Res"},{"key":"446_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1124\/mol.63.3.489","volume":"63","author":"D Bednarczyk","year":"2003","unstructured":"Bednarczyk D, Ekins S, Wikel JH, Wright SH (2003) Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. Mol Pharmacol 63:489\u2013498. https:\/\/doi.org\/10.1124\/mol.63.3.489","journal-title":"Mol Pharmacol"},{"key":"446_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1242\/jeb.196.1.263","volume":"196","author":"RD Blakely","year":"1994","unstructured":"Blakely RD, De Felice LJ, Hartzell HC (1994) Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196:263\u2013281","journal-title":"J Exp Biol"},{"key":"446_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21207581","volume":"21","author":"MA Bowman","year":"2020","unstructured":"Bowman MA, Vitela M, Clarke KM et al (2020) Serotonin transporter and plasma membrane monoamine transporter are necessary for the antidepressant-like effects of ketamine in mice. Int J Mol Sci 21:1\u201322. https:\/\/doi.org\/10.3390\/ijms21207581","journal-title":"Int J Mol Sci"},{"key":"446_CR11","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1523\/jneurosci.18-13-04854.1998","volume":"18","author":"MA Bunin","year":"1998","unstructured":"Bunin MA, Wightman RM (1998) Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission. J Neurosci 18:4854\u20134860. https:\/\/doi.org\/10.1523\/jneurosci.18-13-04854.1998","journal-title":"J Neurosci"},{"key":"446_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0166-2236(99)01410-1","volume":"22","author":"MA Bunin","year":"1999","unstructured":"Bunin MA, Wightman RM (1999) Paracrine neurotransmission in the CNS: involvement of 5-HT. Trends Neurosci 22:377\u2013382. https:\/\/doi.org\/10.1016\/S0166-2236(99)01410-1","journal-title":"Trends Neurosci"},{"key":"446_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.ne.10.030187.000315","volume":"10","author":"A Carlsson","year":"1987","unstructured":"Carlsson A (1987) Perspectives on the discovery of central monoaminergic neurotransmission. Annu Rev Neurosci 10:19\u201340. https:\/\/doi.org\/10.1146\/annurev.ne.10.030187.000315","journal-title":"Annu Rev Neurosci"},{"key":"446_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/FPC.0b013e32834c0010","volume":"21","author":"MMH Christensen","year":"2011","unstructured":"Christensen MMH, Brasch-Andersen C, Green H et al (2011) The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c. Pharmacogenet Genomics 21:837\u2013850. https:\/\/doi.org\/10.1097\/FPC.0b013e32834c0010","journal-title":"Pharmacogenet Genomics"},{"key":"446_CR15","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1681\/ASN.2004040256","volume":"16","author":"G Ciarimboli","year":"2005","unstructured":"Ciarimboli G, Koepsell H, Iordanova M et al (2005) Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation. J Am Soc Nephrol 16:1562\u20131570. https:\/\/doi.org\/10.1681\/ASN.2004040256","journal-title":"J Am Soc Nephrol"},{"key":"446_CR16","doi-asserted-by":"publisher","unstructured":"Collins MA, Neafsey EJ (2000) \u00df-Carboline analogues of MPP+ as environmental neurotoxins. In: Storch A, Collins MA (eds) Neurotoxic factors in Parkinson\u2019s disease and related disorders. Springer US, Boston, MA, pp 115\u2013130. https:\/\/doi.org\/10.1007\/978-1-4615-1269-1_13","DOI":"10.1007\/978-1-4615-1269-1_13"},{"key":"446_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/00008480-199608000-00008","volume":"8","author":"EH Cook","year":"1996","unstructured":"Cook EH, Leventhal BL (1996) The serotonin system in autism. Curr Opin Pediatr 8:348\u2013354. https:\/\/doi.org\/10.1097\/00008480-199608000-00008","journal-title":"Curr Opin Pediatr"},{"key":"446_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/wps.20229","volume":"14","author":"PJ Cowen","year":"2015","unstructured":"Cowen PJ, Browning M (2015) What has serotonin to do with depression? World Psychiatry 14:158\u2013160. https:\/\/doi.org\/10.1002\/wps.20229","journal-title":"World Psychiatry"},{"key":"446_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/sj.npp.1301406","volume":"33","author":"S Cross","year":"2008","unstructured":"Cross S, Kim SJ, Weiss LA et al (2008) Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology 33:353\u2013360. https:\/\/doi.org\/10.1038\/sj.npp.1301406","journal-title":"Neuropsychopharmacology"},{"key":"446_CR20","doi-asserted-by":"publisher","first-page":"8043","DOI":"10.1073\/pnas.0900358106","volume":"106","author":"M Cui","year":"2009","unstructured":"Cui M, Aras R, Christian WV et al (2009) The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A 106:8043\u20138048. https:\/\/doi.org\/10.1073\/pnas.0900358106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"446_CR21","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.neuroscience.2007.01.072","volume":"146","author":"A Dahlin","year":"2007","unstructured":"Dahlin A, Xia L, Kong W et al (2007) Expression and immunolocalization of the plasma membrane monoamine transporter in the brain. Neuroscience 146:1193\u20131211. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.01.072","journal-title":"Neuroscience"},{"key":"446_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1124\/jpet.108.149831","volume":"329","author":"A Dahlin","year":"2009","unstructured":"Dahlin A, Royall J, Hohmann JG, Wang J (2009) Expression profiling of the solute carrier gene family in the mouse brain. J Pharmacol Exp Ther 329:558\u2013570. https:\/\/doi.org\/10.1124\/jpet.108.149831","journal-title":"J Pharmacol Exp Ther"},{"key":"446_CR23","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2337\/dc18-2182","volume":"42","author":"AY Dawed","year":"2019","unstructured":"Dawed AY, Zhou K, van Leeuwen N et al (2019) Variation in the plasma membrane monoamine transporter (PMAT) (encoded by SLC29A4) and organic cation transporter 1 (OCT1) (encoded by SLC22A1) and gastrointestinal intolerance to metformin in type 2 diabetes: an IMI direct study. Diabetes Care 42:1027\u20131033. https:\/\/doi.org\/10.2337\/dc18-2182","journal-title":"Diabetes Care"},{"key":"446_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pharmthera.2008.10.004","volume":"121","author":"LC Daws","year":"2009","unstructured":"Daws LC (2009) Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther 121:89\u201399. https:\/\/doi.org\/10.1016\/j.pharmthera.2008.10.004","journal-title":"Pharmacol Ther"},{"key":"446_CR25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10545-010-9200-9","volume":"33","author":"E De Grandis","year":"2010","unstructured":"De Grandis E, Serrano M, P\u00e9rez-Due\u00f1as B et al (2010) Cerebrospinal fluid alterations of the serotonin product, 5-hydroxyindolacetic acid, in neurological disorders. J Inherit Metab Dis 33:803\u2013809. https:\/\/doi.org\/10.1007\/s10545-010-9200-9","journal-title":"J Inherit Metab Dis"},{"key":"446_CR26","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1124\/jpet.110.170142","volume":"335","author":"H Duan","year":"2010","unstructured":"Duan H, Wang J (2010) Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J Pharmacol Exp Ther 335:743\u2013753. https:\/\/doi.org\/10.1124\/jpet.110.170142","journal-title":"J Pharmacol Exp Ther"},{"key":"446_CR27","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1074\/jbc.M112.436972","volume":"288","author":"H Duan","year":"2013","unstructured":"Duan H, Wang J (2013) Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene. J Biol Chem 288:3535\u20133544. https:\/\/doi.org\/10.1074\/jbc.M112.436972","journal-title":"J Biol Chem"},{"key":"446_CR28","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1124\/dmd.115.064824","volume":"43","author":"H Duan","year":"2015","unstructured":"Duan H, Hu T, Foti RS et al (2015) Potent and selective inhibition of plasma membrane monoamine transporter by HIV protease inhibitors. Drug Metab Dispos 43:1773\u20131780. https:\/\/doi.org\/10.1124\/dmd.115.064824","journal-title":"Drug Metab Dispos"},{"key":"446_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40262-013-0046-9","volume":"52","author":"JK Duong","year":"2013","unstructured":"Duong JK, Kumar SS, Kirkpatrick CM et al (2013) Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function. Clin Pharmacokinet 52:373\u2013384. https:\/\/doi.org\/10.1007\/s40262-013-0046-9","journal-title":"Clin Pharmacokinet"},{"key":"446_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0163-7258(01)00144-9","volume":"91","author":"G Eisenhofer","year":"2001","unstructured":"Eisenhofer G (2001) The role of neuronal and extraneuronal plasma membrane transporters. Pharmacol Ther 91:35\u201362","journal-title":"Pharmacol Ther"},{"key":"446_CR31","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1124\/mol.105.016832","volume":"68","author":"K Engel","year":"2005","unstructured":"Engel K, Wang J (2005) Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol Pharmacol 68:1397\u20131407. https:\/\/doi.org\/10.1124\/mol.105.016832","journal-title":"Mol Pharmacol"},{"key":"446_CR32","doi-asserted-by":"publisher","first-page":"50042","DOI":"10.1074\/jbc.M407913200","volume":"279","author":"K Engel","year":"2004","unstructured":"Engel K, Zhou M, Wang J (2004) Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279:50042\u201350049. https:\/\/doi.org\/10.1074\/jbc.M407913200","journal-title":"J Biol Chem"},{"key":"446_CR33","unstructured":"Frazer A, Hensler JG (1999) Serotonin involvement in physiological function and behavior. In: Siegel GJ, Agranoff BW, Albers RW, et al. (eds) Basic neurochemistry: molecular, cellular and medical aspects, 6th edn. Lippincott-Raven, Philadelphia. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK27940\/"},{"key":"446_CR34","doi-asserted-by":"publisher","first-page":"8758","DOI":"10.1523\/JNEUROSCI.0570-06.2006","volume":"26","author":"PJ Gasser","year":"2006","unstructured":"Gasser PJ, Lowry CA, Orchinik M (2006) Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci 26:8758\u20138766. https:\/\/doi.org\/10.1523\/JNEUROSCI.0570-06.2006","journal-title":"J Neurosci"},{"key":"446_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/cne.21921","volume":"512","author":"PJ Gasser","year":"2009","unstructured":"Gasser PJ, Orchinik M, Raju I, Lowry CA (2009) Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain. J Comp Neurol 512:529\u2013555. https:\/\/doi.org\/10.1002\/cne.21921","journal-title":"J Comp Neurol"},{"key":"446_CR36","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/ejn.13968","volume":"48","author":"TL Gilman","year":"2018","unstructured":"Gilman TL, George CM, Vitela M et al (2018) Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviours. Eur J Neurosci 48:1706\u20131716. https:\/\/doi.org\/10.1111\/ejn.13968","journal-title":"Eur J Neurosci"},{"key":"446_CR37","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1152\/ajpgi.90672.2008","volume":"296","author":"R Govindarajan","year":"2009","unstructured":"Govindarajan R, Leung GPH, Zhou M et al (2009) Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. Am J Physiol Gastrointest Liver Physiol 296:910\u2013922. https:\/\/doi.org\/10.1152\/ajpgi.90672.2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"446_CR38","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1126\/science.294.5544.1024","volume":"294","author":"P Greengard","year":"2001","unstructured":"Greengard P (2001) The neurobiology of slow synaptc transmission. Science 294:1024\u20131030. https:\/\/doi.org\/10.1126\/science.294.5544.1024","journal-title":"Science"},{"key":"446_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/1557","volume":"1","author":"D Gr\u00fcndemann","year":"1998","unstructured":"Gr\u00fcndemann D, Schechinger B, Rappold GA, Sch\u00f6mig E (1998) Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1:349\u2013351. https:\/\/doi.org\/10.1038\/1557","journal-title":"Nat Neurosci"},{"key":"446_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.56.1.1","volume":"56","author":"D Gr\u00fcndemann","year":"1999","unstructured":"Gr\u00fcndemann D, Liebich G, Kiefer N et al (1999) Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 56:1\u201310. https:\/\/doi.org\/10.1124\/mol.56.1.1","journal-title":"Mol Pharmacol"},{"key":"446_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00210-009-0479-8","volume":"381","author":"B Haenisch","year":"2010","unstructured":"Haenisch B, B\u00f6nisch H (2010) Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics. Naunyn Schmiedebergs Arch Pharmacol 381:33\u201339. https:\/\/doi.org\/10.1007\/s00210-009-0479-8","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"446_CR42","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.bjp.0704785","volume":"136","author":"M Hayer-Zillgen","year":"2002","unstructured":"Hayer-Zillgen M, Br\u00fcss M, B\u00f6nisch H (2002) Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 136:829\u2013836. https:\/\/doi.org\/10.1038\/sj.bjp.0704785","journal-title":"Br J Pharmacol"},{"key":"446_CR43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0014-2999(70)90062-2","volume":"12","author":"ED Hendley","year":"1970","unstructured":"Hendley ED, Taylor KM, Snyder SH (1970) 3H-Normetanephrine uptake in rat brain slices. Relationship to extraneuronal accumulation of norepinephrine. Eur J Pharmacol 12:167\u2013179","journal-title":"Eur J Pharmacol"},{"key":"446_CR44","doi-asserted-by":"publisher","first-page":"7839","DOI":"10.1021\/bi100560q","volume":"49","author":"HTB Ho","year":"2010","unstructured":"Ho HTB, Wang J (2010) Tyrosine 112 is essential for organic cation transport by the plasma membrane monoamine transporter. Biochemistry 49:7839\u20137846. https:\/\/doi.org\/10.1021\/bi100560q","journal-title":"Biochemistry"},{"key":"446_CR45","first-page":"107","volume-title":"Drug transporters: molecular characterization and role in drug disposition","author":"HTB Ho","year":"2014","unstructured":"Ho HTB, Wang J (2014) The nucleoside transporters CNT and ENT. In: You G, Morris ME (eds) Drug transporters: molecular characterization and role in drug disposition. Wiley, Hoboken, pp 107\u2013126"},{"key":"446_CR46","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1124\/jpet.111.184036","volume":"339","author":"HTB Ho","year":"2011","unstructured":"Ho HTB, Pan Y, Cui Z et al (2011) Molecular analysis and structure-activity relationship modeling of the substrate\/inhibitor interaction site of plasma membrane monoamine transporter. J Pharmacol Exp Ther 339:376\u2013385. https:\/\/doi.org\/10.1124\/jpet.111.184036","journal-title":"J Pharmacol Exp Ther"},{"key":"446_CR47","doi-asserted-by":"publisher","unstructured":"Ho HTB, Dahlinf A, Wang J (2012a) Expression profiling of solute carrier gene families at the blood-CSF barrier. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2012.00154","DOI":"10.3389\/fphar.2012.00154"},{"key":"446_CR48","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.bcp.2012.04.018","volume":"84","author":"HTB Ho","year":"2012","unstructured":"Ho HTB, Xia L, Wang J (2012b) Residue Ile89 in human plasma membrane monoamine transporter influences its organic cation transport activity and sensitivity to inhibition by dilazep. Biochem Pharmacol 84:383\u2013390. https:\/\/doi.org\/10.1016\/j.bcp.2012.04.018","journal-title":"Biochem Pharmacol"},{"key":"446_CR49","doi-asserted-by":"publisher","first-page":"10534","DOI":"10.1523\/JNEUROSCI.5687-11.2013","volume":"33","author":"RE Horton","year":"2013","unstructured":"Horton RE, Apple DM, Owens WA et al (2013) Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression. J Neurosci 33:10534\u201310543. https:\/\/doi.org\/10.1523\/JNEUROSCI.5687-11.2013","journal-title":"J Neurosci"},{"key":"446_CR50","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1113\/jphysiol.2014.285312","volume":"593","author":"PS Hosford","year":"2015","unstructured":"Hosford PS, Millar J, Ramage AG (2015) Cardiovascular afferents cause the release of 5-HT in the nucleus tractus solitarii; this release is regulated by the low- (PMAT) not the high-affinity transporter (SERT). J Physiol 593:1715\u20131729. https:\/\/doi.org\/10.1113\/jphysiol.2014.285312","journal-title":"J Physiol"},{"key":"446_CR51","doi-asserted-by":"publisher","unstructured":"Hsu C-L, Lin W, Seshasayee D et al (2012) Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis. Science 335:89\u201392. https:\/\/doi.org\/10.1126\/science.1213682","DOI":"10.1126\/science.1213682"},{"key":"446_CR52","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1124\/dmd.111.042432","volume":"40","author":"S Itagaki","year":"2012","unstructured":"Itagaki S, Ganapathy V, Ho HTB et al (2012) Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter. Drug Metab Dispos 40:1138\u20131143. https:\/\/doi.org\/10.1124\/dmd.111.042432","journal-title":"Drug Metab Dispos"},{"key":"446_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1476-5381.1965.tb01753.x","volume":"25","author":"LL Iversen","year":"1965","unstructured":"Iversen LL (1965) The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: a novel catechol amine uptake process. Br J Pharmacol Chemother 25:18\u201333. https:\/\/doi.org\/10.1111\/j.1476-5381.1965.tb01753.x","journal-title":"Br J Pharmacol Chemother"},{"key":"446_CR54","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1182\/blood-2011-09-336933","volume":"119","author":"G Jedlitschky","year":"2012","unstructured":"Jedlitschky G, Greinacher A, Kroemer HK (2012) Transporters in human platelets: physiologic function and impact for pharmacotherapy. Blood 119:3394\u20133402. https:\/\/doi.org\/10.1182\/blood-2011-09-336933","journal-title":"Blood"},{"key":"446_CR55","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0006-8993(81)90594-1","volume":"204","author":"GP Kaplan","year":"1981","unstructured":"Kaplan GP, Hartman BK, Creveling CR (1981) Localization of catechol-O-methyltransferase in the leptomeninges, choroid plexus and ciliary epithelium: implications for the separation of central and peripheral catechols. Brain Res 204:353\u2013360. https:\/\/doi.org\/10.1016\/0006-8993(81)90594-1","journal-title":"Brain Res"},{"key":"446_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/2045-8118-8-26","volume":"8","author":"RF Keep","year":"2011","unstructured":"Keep RF, Smith DE (2011) Choroid plexus transport: gene deletion studies. Fluids Barriers CNS 8:26. https:\/\/doi.org\/10.1186\/2045-8118-8-26","journal-title":"Fluids Barriers CNS"},{"key":"446_CR57","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1021\/jm2001629","volume":"54","author":"Y Kido","year":"2011","unstructured":"Kido Y, Matsson P, Giacomini KM (2011) Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. J Med Chem 54:4548\u20134558. https:\/\/doi.org\/10.1021\/jm2001629","journal-title":"J Med Chem"},{"key":"446_CR58","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","volume":"24","author":"H Koepsell","year":"2007","unstructured":"Koepsell H, Lips K, Volk C (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24:1227\u20131251. https:\/\/doi.org\/10.1007\/s11095-007-9254-z","journal-title":"Pharm Res"},{"key":"446_CR59","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2174\/1389200043489162","volume":"5","author":"W Kong","year":"2004","unstructured":"Kong W, Engel K, Wang J (2004) Mammalian nucleoside transporters. Curr Drug Metab 5:63\u201384. https:\/\/doi.org\/10.2174\/1389200043489162","journal-title":"Curr Drug Metab"},{"key":"446_CR60","doi-asserted-by":"publisher","unstructured":"Kotake Y, Tasaki Y, Makino Y et al (1995) 1-Benzyl-1,2,3,4-Tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF. J Neurochem. https:\/\/doi.org\/10.1046\/j.1471-4159.1995.65062633.x","DOI":"10.1046\/j.1471-4159.1995.65062633.x"},{"key":"446_CR61","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1124\/pr.108.000869","volume":"63","author":"AS Kristensen","year":"2011","unstructured":"Kristensen AS, Andersen J, Jorgensen TN et al (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63:585\u2013640. https:\/\/doi.org\/10.1124\/pr.108.000869","journal-title":"Pharmacol Rev"},{"key":"446_CR62","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0006-3223(97)00532-5","volume":"45","author":"M Leboyer","year":"1999","unstructured":"Leboyer M, Philippe A, Bouvard M et al (1999) Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol Psychiatry 45:158\u2013163. https:\/\/doi.org\/10.1016\/S0006-3223(97)00532-5","journal-title":"Biol Psychiatry"},{"key":"446_CR63","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1476-5381.1969.tb08502.x","volume":"37","author":"SL Lightman","year":"1969","unstructured":"Lightman SL, Iversen LL (1969) The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart. Br J Pharmacol 37:638\u2013649. https:\/\/doi.org\/10.1111\/j.1476-5381.1969.tb08502.x","journal-title":"Br J Pharmacol"},{"key":"446_CR64","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1021\/acschemneuro.5b00219","volume":"6","author":"F Matthaeus","year":"2015","unstructured":"Matthaeus F, Schloss P, Lau T (2015) Differential uptake mechanisms of fluorescent substrates into stem-cell-derived serotonergic neurons. ACS Chem Nerosci 6:1906\u20131912. https:\/\/doi.org\/10.1021\/acschemneuro.5b00219","journal-title":"ACS Chem Nerosci"},{"key":"446_CR65","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1515\/revneuro-2012-0060","volume":"23","author":"A Meneses","year":"2012","unstructured":"Meneses A, Liy-Salmeron G (2012) Serotonin and emotion, learning and memory. Rev Neurosci 23:543\u2013553. https:\/\/doi.org\/10.1515\/revneuro-2012-0060","journal-title":"Rev Neurosci"},{"key":"446_CR66","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1016\/j.xphs.2017.01.009","volume":"106","author":"Y Mimura","year":"2017","unstructured":"Mimura Y, Yasujima T, Ohta K et al (2017) Functional identification of plasma membrane monoamine transporter (PMAT\/SLC29A4) as an atenolol transporter sensitive to flavonoids contained in Apple juice. J Pharm Sci 106:2592\u20132598. https:\/\/doi.org\/10.1016\/j.xphs.2017.01.009","journal-title":"J Pharm Sci"},{"key":"446_CR67","doi-asserted-by":"publisher","first-page":"e472","DOI":"10.1542\/peds.113.5.e472","volume":"113","author":"R Muhle","year":"2004","unstructured":"Muhle R, Trentacoste SV, Rapin I (2004) The genetics of autism. Pediatrics 113:e472\u2013e486. https:\/\/doi.org\/10.1542\/peds.113.5.e472","journal-title":"Pediatrics"},{"key":"446_CR68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.coph.2011.02.008","volume":"11","author":"DL Murphy","year":"2011","unstructured":"Murphy DL, Moya PR (2011) Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G \u00d7 G and G \u00d7 e differences in health and disease. Curr Opin Pharmacol 11:3\u201310. https:\/\/doi.org\/10.1016\/j.coph.2011.02.008","journal-title":"Curr Opin Pharmacol"},{"key":"446_CR69","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/jnc.12665","volume":"129","author":"F Naganuma","year":"2014","unstructured":"Naganuma F, Yoshikawa T, Nakamura T et al (2014) Predominant role of plasma membrane monoamine transporters in monoamine transport in 1321N1, a human astrocytoma-derived cell line. J Neurochem 129:591\u2013601. https:\/\/doi.org\/10.1111\/jnc.12665","journal-title":"J Neurochem"},{"key":"446_CR70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0168-0102(97)00083-7","volume":"29","author":"T Nagatsu","year":"1997","unstructured":"Nagatsu T (1997) Isoquinoline neurotoxins in the brain and Parkinson\u2019s disease. Neurosci Res 29:99\u2013111. https:\/\/doi.org\/10.1016\/S0168-0102(97)00083-7","journal-title":"Neurosci Res"},{"key":"446_CR71","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1002\/jps.22594","volume":"100","author":"T Okura","year":"2011","unstructured":"Okura T, Kato S, Takano Y et al (2011) Functional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriers. J Pharm Sci 100:3924\u20133938. https:\/\/doi.org\/10.1002\/jps.22594","journal-title":"J Pharm Sci"},{"key":"446_CR72","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.mam.2012.07.002","volume":"34","author":"AB Pramod","year":"2013","unstructured":"Pramod AB, Foster J, Carvelli L, Henry LK (2013) SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol Aspects Med 34:197\u2013219. https:\/\/doi.org\/10.1016\/j.mam.2012.07.002","journal-title":"Mol Aspects Med"},{"key":"446_CR73","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1001\/jama.2017.12141","volume":"318","author":"S Sandin","year":"2017","unstructured":"Sandin S, Lichtenstein P, Kuja-Halkola R et al (2017) The heritability of autism Spectrum disorder. JAMA 318:1182\u20131184. https:\/\/doi.org\/10.1001\/jama.2017.12141","journal-title":"JAMA"},{"key":"446_CR74","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1176\/appi.ajp.161.5.909","volume":"161","author":"JJ Schildkraut","year":"2004","unstructured":"Schildkraut JJ, Mooney JJ (2004) Toward a rapidly acting antidepressant: the Normetanephrine and Extraneuronal monoamine transporter (uptake 2) hypothesis. Am J Psychiatry 161:909\u2013911. https:\/\/doi.org\/10.1176\/appi.ajp.161.5.909","journal-title":"Am J Psychiatry"},{"key":"446_CR75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jchemneu.2016.09.006","volume":"83\u201384","author":"Y Shirasaka","year":"2017","unstructured":"Shirasaka Y, Lee N, Duan H et al (2017) Interspecies comparison of the functional characteristics of plasma membrane monoamine transporter (PMAT) between human, rat and mouse. J Chem Neuroanat 83\u201384:99\u2013106. https:\/\/doi.org\/10.1016\/j.jchemneu.2016.09.006","journal-title":"J Chem Neuroanat"},{"key":"446_CR76","unstructured":"Sian J, Youdim M, Riederer P, Gerlach M (1999) MPTP-induced parkinsonian syndrome. In: Siegel GJ, Agranoff BW, Albers RW, et al. (eds) Basic neurochemistry: molecular, cellular and medical aspects, 6th edn. Lippincott-Raven, Philadelphia. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK27974\/"},{"key":"446_CR77","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/(SICI)1520-6394(1997)6:1<10::AID-DA2>3.0.CO;2-9","volume":"6","author":"DC Steffens","year":"1997","unstructured":"Steffens DC, Krishnan KRR, Helms MJ (1997) Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis. Depress Anxiety 6:10\u201318. https:\/\/doi.org\/10.1002\/(SICI)1520-6394(1997)6:1<10::AID-DA2>3.0.CO;2-9","journal-title":"Depress Anxiety"},{"key":"446_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrn1008","volume":"4","author":"GE Torres","year":"2003","unstructured":"Torres GE, Gainetdinov RR, Caron MG (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4:13\u201325. https:\/\/doi.org\/10.1038\/nrn1008","journal-title":"Nat Rev Neurosci"},{"key":"446_CR79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-7091-8901-6_6","volume":"23","author":"U Trendelenburg","year":"1987","unstructured":"Trendelenburg U, Cassis L, Grohmann M, Langeloh A (1987) The functional coupling of neuronal and extraneuronal transport with intracellular monoamine oxidase. J Neural Transm Suppl 23:91\u2013101. https:\/\/doi.org\/10.1007\/978-3-7091-8901-6_6","journal-title":"J Neural Transm Suppl"},{"key":"446_CR80","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/jnc.13758","volume":"139","author":"T Usui","year":"2016","unstructured":"Usui T, Nakazawa A, Okura T et al (2016) Histamine elimination from the cerebrospinal fluid across the blood\u2013cerebrospinal fluid barrier: involvement of plasma membrane monoamine transporter (PMAT\/SLC29A4). J Neurochem 139:408\u2013418. https:\/\/doi.org\/10.1111\/jnc.13758","journal-title":"J Neurochem"},{"key":"446_CR81","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/j.1476-5381.2010.00759.x","volume":"160","author":"RAB Van Waterschoot","year":"2010","unstructured":"Van Waterschoot RAB, Ter Heine R, Wagenaar E et al (2010) Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1\/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir. Br J Pharmacol 160:1224\u20131233. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00759.x","journal-title":"Br J Pharmacol"},{"key":"446_CR82","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1523\/JNEUROSCI.5147-03.2004","volume":"24","author":"V Vialou","year":"2004","unstructured":"Vialou V, Amphoux A, Zwart R et al (2004) Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci 24:2846\u20132851. https:\/\/doi.org\/10.1523\/JNEUROSCI.5147-03.2004","journal-title":"J Neurosci"},{"key":"446_CR83","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.neuroscience.2006.09.058","volume":"144","author":"V Vialou","year":"2007","unstructured":"Vialou V, Balasse L, Dumas S et al (2007) Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain. Neuroscience 144:616\u2013622. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.09.058","journal-title":"Neuroscience"},{"key":"446_CR84","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/cne.10093","volume":"442","author":"T Vitalis","year":"2002","unstructured":"Vitalis T, Fouquet C, Alvarez C et al (2002) Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse. J Comp Neurol 442:331\u2013347. https:\/\/doi.org\/10.1002\/cne.10093","journal-title":"J Comp Neurol"},{"key":"446_CR85","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.phrs.2016.06.002","volume":"111","author":"DJ Wagner","year":"2016","unstructured":"Wagner DJ, Hu T, Wang J (2016) Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics. Pharmacol Res 111:237\u2013246. https:\/\/doi.org\/10.1016\/j.phrs.2016.06.002","journal-title":"Pharmacol Res"},{"key":"446_CR86","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0304-3940(98)00813-1","volume":"257","author":"W Walz","year":"1998","unstructured":"Walz W, Lang MK (1998) Immunocytochemical evidence for a distinct GFAP-negative subpopulation of astrocytes in the adult rat hippocampus. Neurosci Lett 257:127\u2013130. https:\/\/doi.org\/10.1016\/S0304-3940(98)00813-1","journal-title":"Neurosci Lett"},{"key":"446_CR87","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/cpt.442","volume":"100","author":"J Wang","year":"2016","unstructured":"Wang J (2016) The plasma membrane monoamine transporter (PMAT): structure, function, and role in organic cation disposition. Clin Pharmacol Ther 100:489\u2013499. https:\/\/doi.org\/10.1002\/cpt.442","journal-title":"Clin Pharmacol Ther"},{"key":"446_CR88","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/pcn.12606","volume":"72","author":"MMY Waye","year":"2018","unstructured":"Waye MMY, Cheng HY (2018) Genetics and epigenetics of autism: a review. Psychiatry Clin Neurosci 72:228\u2013244. https:\/\/doi.org\/10.1111\/pcn.12606","journal-title":"Psychiatry Clin Neurosci"},{"key":"446_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14814\/phy2.14395","volume":"8","author":"R Wei","year":"2020","unstructured":"Wei R, Gust SL, Tandio D et al (2020) Deletion of murine slc29a4 modifies vascular responses to adenosine and 5-hydroxytryptamine in a sexually dimorphic manner. Physiol Rep 8:1\u201317. https:\/\/doi.org\/10.14814\/phy2.14395","journal-title":"Physiol Rep"},{"key":"446_CR90","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0361-9230(01)00615-3","volume":"56","author":"PM Whitaker-Azmitia","year":"2001","unstructured":"Whitaker-Azmitia PM (2001) Serotonin and brain development: role in human developmental diseases. Brain Res Bull 56:479\u2013485. https:\/\/doi.org\/10.1016\/S0361-9230(01)00615-3","journal-title":"Brain Res Bull"},{"key":"446_CR91","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/BF00169530","volume":"337","author":"VG Wilson","year":"1988","unstructured":"Wilson VG, Grohmann M, Trendelenburg U (1988) The uptake and O-methylation of 3H-(+)-isoprenaline in rat cerebral cortex slices. Naunyn Schmiedebergs Arch Pharmacol 337:397\u2013405","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"446_CR92","doi-asserted-by":"publisher","first-page":"32776","DOI":"10.1074\/jbc.273.49.32776","volume":"273","author":"X Wu","year":"1998","unstructured":"Wu X, Kekuda R, Huang W et al (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273:32776\u201332786. https:\/\/doi.org\/10.1074\/jbc.273.49.32776","journal-title":"J Biol Chem"},{"key":"446_CR93","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/jnc.13363","volume":"135","author":"KC Wu","year":"2015","unstructured":"Wu KC, Lu YH, Peng YH et al (2015) Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins. J Neurochem 135:1178\u20131188. https:\/\/doi.org\/10.1111\/jnc.13363","journal-title":"J Neurochem"},{"key":"446_CR94","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1152\/ajprenal.00302.2006","volume":"292","author":"L Xia","year":"2007","unstructured":"Xia L, Engel K, Zhou M, Wang J (2007) Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells. Am J Physiol Renal Physiol 292:682\u2013690. https:\/\/doi.org\/10.1152\/ajprenal.00302.2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"446_CR95","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1152\/ajprenal.00046.2009","volume":"296","author":"L Xia","year":"2009","unstructured":"Xia L, Zhou M, Kalhorn TF et al (2009) Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity. Am J Physiol Renal Physiol 296:1307\u20131313. https:\/\/doi.org\/10.1152\/ajprenal.00046.2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"446_CR96","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/glia.22484","volume":"61","author":"T Yoshikawa","year":"2013","unstructured":"Yoshikawa T, Naganuma F, Iida T et al (2013) Molecular mechanism of histamine clearance by primary human astrocytes. Glia 61:905\u2013916. https:\/\/doi.org\/10.1002\/glia.22484","journal-title":"Glia"},{"key":"446_CR97","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bcp.2006.09.008","volume":"73","author":"M Zhou","year":"2007","unstructured":"Zhou M, Engel K, Wang J (2007a) Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochem Pharmacol 73:147\u2013154. https:\/\/doi.org\/10.1016\/j.bcp.2006.09.008","journal-title":"Biochem Pharmacol"},{"key":"446_CR98","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1074\/jbc.M609421200","volume":"282","author":"M Zhou","year":"2007","unstructured":"Zhou M, Xia L, Engel K, Wang J (2007b) Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 family. J Biol Chem 282:3188\u20133195. https:\/\/doi.org\/10.1074\/jbc.M609421200","journal-title":"J Biol Chem"},{"key":"446_CR99","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1124\/dmd.107.015495","volume":"35","author":"M Zhou","year":"2007","unstructured":"Zhou M, Xia L, Wang J (2007c) Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine. Drug Metab Dispos 35:1956\u20131962. https:\/\/doi.org\/10.1124\/dmd.107.015495","journal-title":"Drug Metab Dispos"},{"key":"446_CR100","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1124\/dmd.110.032987","volume":"38","author":"M Zhou","year":"2010","unstructured":"Zhou M, Duan H, Engel K et al (2010) Adenosine transport by plasma membrane monoamine transporter: reinvestigation and comparison with organic cations. Drug Metab Dispos 38:1798\u20131805. https:\/\/doi.org\/10.1124\/dmd.110.032987","journal-title":"Drug Metab Dispos"},{"key":"446_CR101","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00210-008-0369-5","volume":"379","author":"O Zolk","year":"2009","unstructured":"Zolk O, Solbach TF, K\u00f6nig J, Fromm MF (2009) Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2). Naunyn Schmiedebergs Arch Pharmacol 379:337\u2013348. https:\/\/doi.org\/10.1007\/s00210-008-0369-5","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Handbook of Experimental Pharmacology","Organic Cation Transporters in the Central Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2021_446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T23:34:36Z","timestamp":1635291276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2021_446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030829834","9783030829841"],"references-count":101,"URL":"https:\/\/doi.org\/10.1007\/164_2021_446","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"10 March 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}